Medtech’s Leading Revenue Earners In 2023: Johnson & Johnson Tops $30bn
Pandemic’s Endemic State In 2023 Puts Correction On Testing Revenues
Abbott’s weaker rapid diagnostic sales see the erstwhile industry leader slip down the global 2023 medtech rankings, while Johnson & Johnson passes it on the way up on the back of strong external and internal growth.
